ReviewJAC-antimicrobial resistance2026
Beyond borders: Europe's leadership role in tackling transboundary antimicrobial resistance.
Review in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating Research, Policy and Practice to Address Antimicrobial Resistance in Aotearoa New Zealand: The NZAMRNet Initiative.Journal of the Royal Society of New Zealand · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) remains one of the gravest global health threats, responsible for over 35 000 deaths annually in the EU/EEA and projected to cause nearly 2 million deaths worldwide each year by 2050. While Europe has long positioned itself as a frontrunner in the fight against AMR, growing international mobility and fragmented policy implementation continue to undermine progress. This viewpoint argues that strengthening a coordinated One Health response is essential to address the transboundary nature of antimicrobial resistance. The European response must now evolve beyond national and regional frameworks, with strengthened surveillance at borders, stronger political commitment at the continental level, to curb imported and emerging resistant infections. Only a unified, globally connected Europe can lead an effective and sustainable response to this silent pandemic.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.